Willy Hugo
Overview
Explore the profile of Willy Hugo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
8671
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen H, Wang H, Kohn L, Sailer D, Zhang S, McCarthy E, et al.
bioRxiv
. 2025 Jan;
PMID: 39763836
Type 1 Diabetes Mellitus (T1D) is an autoimmune disease caused by unremitting immune attack on pancreas insulin-producing beta cells. Persistence of the autoimmune response is mediated by TCF1+ Ly108+ progenitor...
2.
Seyedsadr M, Bang M, McCarthy E, Zhang S, Chen H, Mohebbi M, et al.
J Clin Invest
. 2024 Aug;
134(15).
PMID: 39087473
Inflammatory neuropathies, which include chronic inflammatory demyelinating polyneuropathy (CIDP) and Guillain Barré syndrome (GBS), result from autoimmune destruction of the PNS and are characterized by progressive weakness and sensory loss....
3.
Hong A, Moriceau G, Sun L, Lomeli S, Piva M, Damoiseaux R, et al.
Cancer Discov
. 2024 Jul;
14(7):1356.
PMID: 38946327
No abstract available.
4.
Hong A, Piva M, Liu S, Hugo W, Lomeli S, Zoete V, et al.
Cancer Discov
. 2024 Jul;
14(7):1357.
PMID: 38946326
No abstract available.
5.
Everson R, Hugo W, Sun L, Antonios J, Lee A, Ding L, et al.
Nat Commun
. 2024 Jun;
15(1):4800.
PMID: 38839763
No abstract available.
6.
Zhang D, Hugo W, Bergsneider M, Wang M, Kim W, Han K, et al.
Eur J Endocrinol
. 2024 May;
190(6):467-478.
PMID: 38781434
Objective: Unravel the potential mechanism(s) of the on- and off-target actions of dopamine agonist therapy in both human prolactinoma tumors and neighboring stromal and immune cells. Design And Methods: Five...
7.
Everson R, Hugo W, Sun L, Antonios J, Lee A, Ding L, et al.
Nat Commun
. 2024 May;
15(1):3882.
PMID: 38719809
In this randomized phase II clinical trial, we evaluated the effectiveness of adding the TLR agonists, poly-ICLC or resiquimod, to autologous tumor lysate-pulsed dendritic cell (ATL-DC) vaccination in patients with...
8.
Seyedsadr M, Bang M, McCarthy E, Zhang S, Chen H, Mohebbi M, et al.
bioRxiv
. 2024 Jan;
PMID: 38260637
Inflammatory neuropathies, which include CIDP (chronic inflammatory demyelinating polyneuropathy) and GBS (Guillain Barre Syndrome), result from autoimmune destruction of the peripheral nervous system (PNS) and are characterized by progressive weakness...
9.
Everson R, Hugo W, Sun L, Antonios J, Lee A, Ding L, et al.
Res Sq
. 2023 Oct;
PMID: 37790490
Trial Registration: ClinicalTrials.gov Identifier: NCT01204684.
10.
Sun L, Kienzler J, Reynoso J, Lee A, Shiuan E, Li S, et al.
J Clin Invest
. 2023 Sep;
133(17).
PMID: 37655659
In comparison with responses in recurrent glioblastoma (rGBM), the intracranial response of brain metastases (BrM) to immune checkpoint blockade (ICB) is less well studied. Here, we present an integrated single-cell...